Impact of NA‐1 on Pericyte‐Driven Vasoconstriction and Its Role in No‐Reflow During Cerebral Ischemia–Reperfusion
Open Access
- 25 May 2025
- journal article
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 31 (5) , e70409
Abstract
Background: The no‐reflow phenomenon in the ischemic brain following arterial recanalization leads to poor prognosis. Previous studies suggest that the clinically proven NA‐1 drug, with disruption of PSD95 in the neuronal terminals alongside the cerebral microvasculature, may inhibit pericytic contraction of microvessels by reducing endothelin‐1 secretion.Methods: A 1.5‐h tMCAO model using Balb/c mice was employed. In vivo two‐photon imaging and immunofluorescence staining were employed to assess the constriction effect of pericytes on capillaries. The impact of NR2B9c/NA‐1 administration (intravenously infused at a dose of 10 μmol/kg) on pericyte constriction was evaluated through immunofluorescent staining of brain sections. Additionally, The effect of NA‐1 on cerebral perfusion was assessed using laser speckle blood flow monitoring, whole brain slice perfusion, and high‐magnification capillary imaging. Enzyme‐linked immunosorbent Assay (ELISA) was conducted to determine changes in quantitative ONOO− and endothelin‐1 (ET‐1) content after tat‐NA‐1 administration. Lastly, microtubule‐associated protein 2 (MAP2) staining and behavioral scores were used to evaluate the effects of NA‐1 on infarct size and behavioral deficits.Results: In vivo two‐photon imaging and immunofluorescence staining revealed that pericyte constriction following ischemia and recanalization resulted in a decreased diameter of capillaries, particularly at the soma and adjacent areas. Notably, capillary obstruction was localized near pericytes. After administration of NA‐1, the immunofluorescence staining section showed that the diameter of capillaries at pericytes' soma and in the adjacent parts increased. The ELISA results indicated a reduction in ONOO− and ET‐1 levels. Additionally, MAP2 staining revealed a decrease in infarct size, while behavioral scores showed improvements in deficits. This effect of NA‐1 was counteracted notably when added ET‐1.Conclusion: NA‐1 inhibits pericyte constriction following ischemia–reperfusion by reducing ET‐1 levels. It improves capillary no‐reflow in mice, enhances cerebral perfusion, decreases infarct size, and mitigates behavioral deficits.Keywords
Funding Information
- National Natural Science Foundation of China (81820108012, 82001920, 82071301)
This publication has 48 references indexed in Scilit:
- Bidirectional control of CNS capillary diameter by pericytesNature, 2006
- Calcium influx pathways in rat CNS pericytesMolecular Brain Research, 2004
- Cholinergic modulation of the cortical microvascular bed2004
- Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemiaPeptides, 2002
- Intravenous Administration of Human Umbilical Cord Blood Reduces Behavioral Deficits After Stroke in RatsStroke, 2001
- Nitric Oxide/cGMP-Induced Inhibition of Calcium and Chloride Currents in Retinal PericytesMicrovascular Research, 2001
- Adenosine activates ATP-sensitive K+ currents in pericytes of rat retinal microvessels: role of A1 and A2a receptorsBrain Research, 2001
- Intrastriatal Transplantation of Bone Marrow Nonhematopoietic Cells Improves Functional Recovery After Stroke in Adult MiceJournal of Cerebral Blood Flow & Metabolism, 2000
- In SituObservation of Living Pericytes in Rat Retinal CapillariesMicrovascular Research, 1998
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989